CN103249741B - 肽 - Google Patents

肽 Download PDF

Info

Publication number
CN103249741B
CN103249741B CN201180059041.2A CN201180059041A CN103249741B CN 103249741 B CN103249741 B CN 103249741B CN 201180059041 A CN201180059041 A CN 201180059041A CN 103249741 B CN103249741 B CN 103249741B
Authority
CN
China
Prior art keywords
peptide
fty
fsy
food
ace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180059041.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN103249741A (zh
Inventor
J·拉沃
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marealis AS
Original Assignee
Marealis AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marealis AS filed Critical Marealis AS
Publication of CN103249741A publication Critical patent/CN103249741A/zh
Application granted granted Critical
Publication of CN103249741B publication Critical patent/CN103249741B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201180059041.2A 2010-10-26 2011-07-13 肽 Active CN103249741B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018125.3A GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide
GB1018125.3 2010-10-26
PCT/GB2011/051314 WO2012056205A1 (en) 2010-10-26 2011-07-13 Peptide

Publications (2)

Publication Number Publication Date
CN103249741A CN103249741A (zh) 2013-08-14
CN103249741B true CN103249741B (zh) 2015-12-02

Family

ID=43365585

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180059041.2A Active CN103249741B (zh) 2010-10-26 2011-07-13 肽

Country Status (11)

Country Link
US (2) US9044511B2 (https=)
EP (1) EP2632937B8 (https=)
JP (1) JP5879356B2 (https=)
CN (1) CN103249741B (https=)
AU (1) AU2011322287B2 (https=)
BR (1) BR112013009679B1 (https=)
CA (1) CA2856153C (https=)
DK (1) DK2632937T3 (https=)
GB (1) GB201018125D0 (https=)
RU (1) RU2572623C2 (https=)
WO (1) WO2012056205A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337711A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Pro‑Hyp及应用和药物组合物
CN107325153A (zh) * 2017-07-26 2017-11-07 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Hyp‑Pro及应用和药物组合物
JPWO2021059840A1 (ja) * 2019-09-27 2021-10-07 太陽化学株式会社 アンジオテンシン変換酵素阻害剤
TWI890506B (zh) * 2024-06-27 2025-07-11 開曼群島商味丹國際（控股）有限公司 具有抑制ace活性之胜肽及其組合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1780851A (zh) * 2003-05-01 2006-05-31 科内尔研究基金会 将分子递送到细胞的方法和载体复合物
CN101217971A (zh) * 2005-07-05 2008-07-09 比奥滕普特公司 肿瘤的治疗

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455303A (en) * 1983-05-24 1984-06-19 The General Hospital Corporation Renin inhibitors
US5545719A (en) 1990-05-01 1996-08-13 Neuromedica, Inc. Nerve growth peptides
RU2084458C1 (ru) * 1993-05-27 1997-07-20 Институт высокомолекулярных соединений РАН Декапептид, обладающий противоопухолевой активностью
WO2005007090A2 (en) * 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
AU2003253301A1 (en) 2003-07-31 2004-07-14 Franco Felici Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
HUP0600814A3 (en) * 2006-10-27 2009-08-28 Biostatin Gyogyszerkutato Fejl Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
CN101092450A (zh) * 2007-01-10 2007-12-26 中国人民解放军第三军医大学第一附属医院 与人mhc－ⅰ类分子结合的肝素酶多肽表位
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance
FR2943346B1 (fr) 2009-03-19 2011-05-06 Univ Paris Curie Peptides modulant l'activite de l'igf-1 et leurs applications
GB201008462D0 (en) 2010-05-20 2010-07-07 Marealis As Process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1780851A (zh) * 2003-05-01 2006-05-31 科内尔研究基金会 将分子递送到细胞的方法和载体复合物
CN101217971A (zh) * 2005-07-05 2008-07-09 比奥滕普特公司 肿瘤的治疗

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Angiotensin I–converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects;Guan-Hong Li et al.;《Nutrition Research》;20040731;第24卷(第7期);第470段图1，第471页第1段，第473页表1，第474页第2段，第475页最后一段，第480页第1段 *
Latent Production of Angiotensin I-Converting Enzyme Inhibitors from Buckwheat Protein;CHUN-HUI LI et al.;《J. Peptide Sci.》;20020601;第8卷(第6期);第271页左栏第2段，第272页表2， *

Also Published As

Publication number Publication date
CN103249741A (zh) 2013-08-14
US20130281358A1 (en) 2013-10-24
JP5879356B2 (ja) 2016-03-08
BR112013009679A2 (pt) 2016-07-12
WO2012056205A1 (en) 2012-05-03
RU2572623C2 (ru) 2016-01-20
JP2014500245A (ja) 2014-01-09
EP2632937A1 (en) 2013-09-04
CA2856153C (en) 2019-04-16
RU2013124991A (ru) 2014-12-10
AU2011322287A1 (en) 2013-05-02
EP2632937B1 (en) 2016-03-16
GB201018125D0 (en) 2010-12-08
AU2011322287B2 (en) 2015-06-25
CA2856153A1 (en) 2012-05-03
EP2632937B8 (en) 2016-06-22
US9044511B2 (en) 2015-06-02
BR112013009679B1 (pt) 2020-12-01
DK2632937T3 (en) 2016-05-30
US20150315236A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
Xue et al. Activity and bioavailability of food protein‐derived angiotensin‐I‐converting enzyme–inhibitory peptides
Saleh et al. Recent research in antihypertensive activity of food protein-derived hydrolyzates and peptides
US10308681B2 (en) Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
WO2010125192A1 (en) Use of a casein-derived peptide and compositions thereof as antihypertensive
CN104159912B (zh) 二肽基肽酶iv 抑制剂
CN103249741B (zh) 肽
JPWO2013133032A1 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP5877560B2 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
US20090203621A1 (en) Tripeptides that Down Regulate the Activity of Plasma Membrane transporters Including Sodium-D-Glucose Cotransporter Sglt1
KR101404850B1 (ko) 클로렐라 유래 항고혈압 활성을 갖는 펩티드
Wu et al. The nutritional composition and anti-hypertensive activity on spontaneously hypertensive rats of sipuncula Phascolosoma esculenta
Aluko Cardiovascular benefits of food protein-derived bioactive peptides
WO2014030977A1 (ko) 안지오텐신-i 전환 효소 저해능을 나타내는 펩타이드를 유효성분으로 포함하는 심혈관계 질환 예방 또는 치료용 약학적 조성물
EP3170507B1 (en) Antihypertensive peptides from olive oil
JP5430803B2 (ja) ペプチドおよびアンジオテンシン変換酵素阻害剤
JP2006063021A (ja) 高血圧降下剤および高血圧降下作用を有する食品
López-Huertas et al. Antihypertensive peptides from olive oil

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant